Last 7 days
-10.3%
Last 30 days
-18.2%
Last 90 days
33.3%
Trailing 12 Months
-68.4%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
A | 38.9B | 6.8B | -7.12% | -2.94% | 31.04 | 5.68 | 8.37% | 3.64% |
IQV | 35.0B | 14.4B | -10.73% | -16.15% | 32.06 | 2.43 | 3.86% | 12.94% |
ILMN | 34.8B | 4.6B | 9.07% | -35.87% | -7.89 | 7.58 | 1.28% | -677.95% |
CRL | 9.9B | 4.0B | -11.55% | -31.05% | 20.3 | 2.48 | 12.31% | 24.36% |
MID-CAP | ||||||||
MEDP | 5.7B | 1.5B | -7.14% | 13.35% | 23.05 | 3.87 | 27.80% | 34.93% |
SYNH | 3.6B | 5.4B | -7.30% | -56.29% | 13.33 | 0.66 | 3.46% | 13.48% |
SMALL-CAP | ||||||||
PACB | 2.2B | 128.3M | 3.11% | -0.62% | -6.93 | 16.97 | -1.69% | -73.40% |
ADPT | 1.2B | 185.3M | -4.53% | -36.18% | -6.03 | 6.51 | 20.06% | 3.42% |
CSTL | 597.7M | 137.0M | -4.54% | -49.04% | -8.9 | 4.36 | 45.65% | -114.55% |
NVTA | 316.8M | 516.3M | -37.38% | -84.33% | -0.1 | 0.61 | 12.13% | -719.59% |
CDXS | 255.3M | 138.6M | -29.45% | -81.04% | -7.6 | 1.84 | 32.30% | -57.86% |
PSNL | 121.4M | 65.0M | -18.24% | -68.45% | -1.07 | 1.87 | -23.92% | -73.73% |
Income Statement (Last 12 Months) | ||||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | -5.7% | 65,047,000 | 69,007,000 | 76,410,000 | 79,840,000 | 85,494,000 |
S&GA Expenses | 6.9% | 63,969,000 | 59,850,000 | 57,209,000 | 52,763,000 | 47,698,000 |
R&D Expenses | 3.3% | 64,912,000 | 62,855,000 | 61,515,000 | 56,914,000 | 49,312,000 |
EBITDA | -10.0% | -104,642,000 | -95,129,000 | -86,666,000 | -74,450,000 | - |
EBITDA Margin | -16.7% | -1.61 | -1.38 | -1.13 | -0.93 | - |
Earnings Before Taxes | -10.6% | -113,275,000 | -102,417,000 | -93,594,000 | -81,007,000 | -65,212,000 |
EBT Margin | -17.3% | -1.74 | -1.48 | -1.22 | -1.01 | - |
Interest Expenses | -5.6% | 201,000 | 213,000 | 228,000 | 243,000 | 184,000 |
Net Income | -10.6% | -113,315,000 | -102,446,000 | -93,624,000 | -81,031,000 | -65,226,000 |
Net Income Margin | -17.3% | -1.74 | -1.48 | -1.23 | -1.01 | - |
Free Cahsflow | -6.6% | -120,129,000 | -112,680,000 | -97,343,000 | -89,720,000 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | -7.9% | 293 | 318 | 358 | 381 | 397 |
Current Assets | -10.0% | 200 | 222 | 260 | 294 | 318 |
Cash Equivalents | 6.7% | 89.00 | 84.00 | 87.00 | 92.00 | 106 |
Net PPE | 1.2% | 62.00 | 61.00 | 48.00 | 31.00 | 20.00 |
Liabilities | -1.2% | 75.00 | 75.00 | 93.00 | 94.00 | 86.00 |
Current Liabilities | -1.8% | 33.00 | 34.00 | 42.00 | 40.00 | 31.00 |
Shareholder's Equity | -10.0% | 218 | 242 | 265 | 287 | 310 |
Retained Earnings | -9.4% | -360 | -329 | -302 | -275 | -247 |
Additional Paid-In Capital | 1.1% | 579 | 573 | 569 | 563 | 558 |
Accumulated Depreciation | 7.5% | 24.00 | 23.00 | 21.00 | 19.00 | - |
Shares Outstanding | 1.6% | 47.00 | 46.00 | 46.00 | 45.00 | 45.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | -2.2% | -70.23 | -68.74 | -71.86 | -70.44 | -70.83 |
Share Based Compensation | 9.9% | 19.00 | 18.00 | 17.00 | 16.00 | 14.00 |
Cashflow From Investing | -25.6% | 53.00 | 71.00 | 89.00 | 19.00 | -60.07 |
Cashflow From Financing | -38.0% | 1.00 | 2.00 | 1.00 | 7.00 | 170 |
99.0%
97.5%
96.0%
Y-axis is the maximum loss one would have experienced if Personalis was unfortunately bought at previous high price.
-26.4%
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-02-15 | PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | reduced | -33.6 | -42,000 | 34,000 | -% |
2023-02-15 | Bruce & Co., Inc. | new | - | 99,000 | 99,000 | 0.03% |
2023-02-15 | Wellington Shields Capital Management, LLC | reduced | -11.51 | -1,187,990 | 1,709,010 | 0.21% |
2023-02-15 | Wellington Shields & Co., LLC | added | 9.39 | -744,640 | 2,006,360 | 0.46% |
2023-02-15 | JANE STREET GROUP, LLC | reduced | -20.38 | -43,397 | 49,603 | -% |
2023-02-15 | Steward Partners Investment Advisory, LLC | unchanged | - | 198 | 198 | -% |
2023-02-15 | Financial Gravity Asset Management, Inc. | new | - | 8.00 | 8.00 | -% |
2023-02-15 | B. Riley Asset Management, LLC | new | - | 248,827 | 248,827 | 0.11% |
2023-02-14 | Point72 Hong Kong Ltd | sold off | -100 | - | - | -% |
2023-02-14 | LMR Partners LLP | sold off | -100 | -51,000 | - | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Jan 31, 2023 | blackrock inc. | 7.7% | 3,558,913 | SC 13G/A | |
Jan 25, 2023 | jpmorgan chase & co | 7.6% | 3,502,353 | SC 13G/A | |
Mar 09, 2022 | blackrock inc. | 10.0% | 4,502,224 | SC 13G/A | |
Mar 07, 2022 | lightspeed venture partners viii lp | 9.16% | 4,117,768 | SC 13D/A | |
Feb 09, 2022 | ark investment management llc | 10.91% | 4,888,115 | SC 13G/A | |
Feb 03, 2022 | blackrock inc. | 9.8% | 4,389,333 | SC 13G/A | |
Jan 14, 2022 | jpmorgan chase & co | 9.5% | 4,267,659 | SC 13G/A | |
Feb 16, 2021 | abingworth llp | 0.0% | 0 | SC 13G/A | |
Feb 02, 2021 | blackrock inc. | 5.9% | 2,309,401 | SC 13G | |
Jan 15, 2021 | jpmorgan chase & co | 8.5% | 3,340,089 | SC 13G |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 1.19 -54.23% | 1.26 -51.54% | 1.39 -46.54% | 1.65 -36.54% | 1.90 -26.92% |
Current Inflation | 1.19 -54.23% | 1.25 -51.92% | 1.37 -47.31% | 1.60 -38.46% | 1.82 -30.00% |
Very High Inflation | 1.19 -54.23% | 1.24 -52.31% | 1.35 -48.08% | 1.54 -40.77% | 1.73 -33.46% |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 21, 2023 | 4 | Insider Trading | |
Mar 21, 2023 | 4 | Insider Trading | |
Mar 17, 2023 | 4 | Insider Trading | |
Mar 17, 2023 | 4 | Insider Trading | |
Mar 17, 2023 | 4 | Insider Trading | |
Mar 17, 2023 | 4 | Insider Trading | |
Mar 08, 2023 | 8-K | Current Report | |
Feb 23, 2023 | 10-K | Annual Report | |
Feb 23, 2023 | 8-K | Current Report | |
Feb 23, 2023 | S-8 | Employee Benefits Plan |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-17 | Tachibana Aaron | sold | -11,164 | 2.83 | -3,945 | cfo and coo |
2023-03-17 | Chen Richard | sold | -3,718 | 2.83 | -1,314 | chief medical officer and evp |
2023-01-31 | Chen Richard | sold | -1,236 | 2.2 | -562 | chief medical officer |
2023-01-31 | Tachibana Aaron | sold | -1,687 | 2.2 | -767 | chief financial officer |
2022-12-20 | Chen Richard | sold | -3,360 | 1.92 | -1,750 | chief medical officer |
2022-12-20 | Tachibana Aaron | sold | -7,378 | 1.92 | -3,843 | chief financial officer |
2022-12-15 | Chen Richard | sold | -17,942 | 2.5 | -7,177 | chief medical officer |
2022-12-15 | Tachibana Aaron | sold | -17,942 | 2.5 | -7,177 | chief financial officer |
2022-12-15 | Moore Stephen Michael | sold | -4,825 | 2.5 | -1,930 | general counsel |
2022-12-14 | West John Stephen | acquired | 24,400 | 2.44 | 10,000 | president and ceo |
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Statement [Abstract] | |||
Revenue | $ 65,047 | $ 85,494 | $ 78,648 |
Costs and expenses | |||
Cost of revenue | 51,697 | 53,837 | 58,534 |
Research and development | 64,912 | 49,312 | 28,568 |
Selling, general and administrative | 63,969 | 47,698 | 33,692 |
Total costs and expenses | 180,578 | 150,847 | 120,794 |
Loss from operations | (115,531) | (65,353) | (42,146) |
Interest income | 2,396 | 367 | 949 |
Interest expense | (201) | (184) | (2) |
Other income (expense), net | 61 | (42) | (24) |
Loss before income taxes | (113,275) | (65,212) | (41,223) |
Provision for income taxes | 40 | 14 | 57 |
Net loss | $ (113,315) | $ (65,226) | $ (41,280) |
Net loss per share, basic | $ (2.48) | $ (1.49) | $ (1.20) |
Net loss per share, diluted | $ (2.48) | $ (1.49) | $ (1.20) |
Weighted-average shares outstanding, basic | 45,704,805 | 43,886,730 | 34,374,903 |
Weighted-average shares outstanding, diluted | 45,704,805 | 43,886,730 | 34,374,903 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 89,128 | $ 105,585 |
Short-term investments | 78,530 | 181,479 |
Accounts receivable, net | 16,642 | 18,468 |
Inventory and other deferred costs | 8,591 | 5,610 |
Prepaid expenses and other current assets | 6,808 | 7,089 |
Total current assets | 199,699 | 318,231 |
Property and equipment, net | 61,935 | 19,650 |
Operating lease right-of-use assets | 26,480 | 53,822 |
Other long-term assets | 4,586 | 4,825 |
Total assets | 292,700 | 396,528 |
Current liabilities | ||
Accounts payable | 12,854 | 9,221 |
Accrued and other current liabilities | 19,013 | 18,110 |
Contract liabilities | 1,264 | 3,982 |
Total current liabilities | 33,131 | 31,313 |
Long-term operating lease liabilities | 41,041 | 52,797 |
Other long-term liabilities | 389 | 2,117 |
Total liabilities | 74,561 | 86,227 |
Commitments and contingencies (Note 12) | ||
Stockholders’ equity | ||
Common stock, $0.0001 par value - 200,000,000 shares authorized; 46,707,084 and 44,904,512 shares issued and outstanding at December 31, 2022 and 2021, respectively | 5 | 4 |
Additional paid-in capital | 579,456 | 557,558 |
Accumulated other comprehensive loss | (912) | (166) |
Accumulated deficit | (360,410) | (247,095) |
Total stockholders’ equity | 218,139 | 310,301 |
Total liabilities and stockholders’ equity | $ 292,700 | $ 396,528 |